These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 1775633)

  • 1. Stimulation of prostaglandin D2 receptors on human platelets by analogs of prostacyclin.
    Alvarez R; Eglen RM; Chang LF; Bruno JJ; Artis DR; Kluge AF; Whiting RL
    Prostaglandins; 1991 Aug; 42(2):105-19. PubMed ID: 1775633
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The antagonism by BW A868C of PGD2 and BW245C activation of human platelet adenylate cyclase.
    Trist DG; Collins BA; Wood J; Kelly MG; Robertson AD
    Br J Pharmacol; 1989 Feb; 96(2):301-6. PubMed ID: 2466517
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of human platelets and polymorphonuclear neutrophils by the potent and metabolically stable prostaglandin D2 analog ZK 118.182.
    Darius H; Michael-Hepp J; Thierauch KH; Fisch A
    Eur J Pharmacol; 1994 Jun; 258(3):207-13. PubMed ID: 7522176
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Specificity between the anti-aggregatory actions of prostacyclin, prostaglandin E1 and D2 on platelets.
    Whittle BJ; Hamid S; Lidbury P; Rosam AC
    Adv Exp Med Biol; 1985; 192():109-25. PubMed ID: 2871707
    [No Abstract]   [Full Text] [Related]  

  • 5. SQ-27986 inhibition of platelet aggregation is mediated through activation of platelet prostaglandin D2 receptors.
    Seiler S; Brassard CL; Federici ME
    Prostaglandins; 1990 Aug; 40(2):119-30. PubMed ID: 2171039
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The classification of prostaglandin DP-receptors in platelets and vasculature using BW A868C, a novel, selective and potent competitive antagonist.
    Giles H; Leff P; Bolofo ML; Kelly MG; Robertson AD
    Br J Pharmacol; 1989 Feb; 96(2):291-300. PubMed ID: 2924081
    [TBL] [Abstract][Full Text] [Related]  

  • 7. (5Z)-carbacyclin discriminates between prostacyclin-receptors coupled to adenylate cyclase in vascular smooth muscle and platelets.
    Corsini A; Folco GC; Fumagalli R; Nicosia S; Noe MA; Oliva D
    Br J Pharmacol; 1987 Jan; 90(1):255-61. PubMed ID: 3545351
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Octimibate, a potent non-prostanoid inhibitor of platelet aggregation, acts via the prostacyclin receptor.
    Merritt JE; Hallam TJ; Brown AM; Boyfield I; Cooper DG; Hickey DM; Jaxa-Chamiec AA; Kaumann AJ; Keen M; Kelly E
    Br J Pharmacol; 1991 Jan; 102(1):251-9. PubMed ID: 1710526
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Octimibate inhibition of platelet aggregation: stimulation of adenylate cyclase through prostacyclin receptor activation.
    Seiler S; Brassard CL; Arnold AJ; Meanwell NA; Fleming JS; Keely SL
    J Pharmacol Exp Ther; 1990 Dec; 255(3):1021-6. PubMed ID: 2175792
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prostacyclin stimulation of the activation of blood coagulation factor X by platelets.
    Dutta-Roy AK; Ray TK; Sinha AK
    Science; 1986 Jan; 231(4736):385-8. PubMed ID: 3001935
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The binding of 6-oxo-prostaglandin E1 to platelet prostanoid receptors.
    Jaschonek K; Renn W; Weisenberger H
    Prostaglandins Leukot Med; 1986 Sep; 24(1):79-86. PubMed ID: 3020591
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antagonism of PGD2 vasodepressor responses in the rat in vivo by the novel, selective antagonist, BW A868C.
    Hamid-Bloomfield S; Whittle BJ
    Br J Pharmacol; 1989 Feb; 96(2):307-12. PubMed ID: 2647205
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interaction of prostaglandin D2 with prostacyclin, carbacyclin and the hydantoin prostaglandin, BW245C, in guinea-pig platelets.
    Hamid S; Whittle BJ
    Br J Pharmacol; 1985 May; 85(1):285-90. PubMed ID: 2992652
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synergistic interaction of adenylate cyclase activators and nitric oxide donor SIN-1 on platelet cyclic AMP.
    Fisch A; Michael-Hepp J; Meyer J; Darius H
    Eur J Pharmacol; 1995 May; 289(3):455-61. PubMed ID: 7556414
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Refractoriness of platelets to prostaglandins after infusion in rabbits.
    Bertelé V; Stemerman M; Schafer A; Adelman B; Smith M; Fuhro R; Salzman E
    J Lab Clin Med; 1985 Nov; 106(5):551-61. PubMed ID: 2997353
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytochemical localization of adenylate cyclase in the dense tubule system of human blood platelets stimulated by forskolin, prostacyclin and prostaglandin D2.
    Cutler LS; Christian CP; Feinstein MB
    Biochim Biophys Acta; 1985 Jun; 845(3):403-10. PubMed ID: 3890960
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel mechanism of heterologous desensitization of adenylate cyclase: prostaglandins bind with different affinities to both stimulatory and inhibitory receptors on platelets.
    Ashby B
    Mol Pharmacol; 1990 Jul; 38(1):46-53. PubMed ID: 1695318
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Desacetyl-1-nantradol: a selective prostaglandin antagonist.
    Horne WC
    Prostaglandins Leukot Med; 1984 Jul; 15(1):129-36. PubMed ID: 6147860
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The use of stable prostaglandins to investigate prostacyclin (PGI2)-binding sites and PGI2-sensitive adenylate cyclase in human platelet membranes.
    Lombroso M; Nicosia S; Paoletti R; Whittle BJ; Moncada S; Vane JR
    Prostaglandins; 1984 Feb; 27(2):321-33. PubMed ID: 6326201
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prostaglandin DP receptors positively coupled to adenylyl cyclase in embryonic bovine tracheal (EBTr) cells: pharmacological characterization using agonists and antagonists.
    Crider JY; Griffin BW; Sharif NA
    Br J Pharmacol; 1999 May; 127(1):204-10. PubMed ID: 10369474
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.